Glaxo’s Sales Climb in First Quarter on Pandemic Stockpiling

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc joined drugmakers whose sales have benefited from patients’ stockpiling ahead of coronavirus lockdowns.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.